Screening pathogenic gene mutation of hypertrophic cardiomyopathy by high throughput sequencing technology

WANG Cong,BU Li-ping,SUN Ai-jun,ZHOU Jing-min,QIAN Ju-ying,GE Jun-bo
DOI: https://doi.org/10.3969/j.issn.1673-6087.2012.05.010
2012-01-01
Abstract:Objective To screen the pathogenic gene mutation of patients with hypertrophic cardiomyopathy(HCM) by high throughput sequencing technology and studying the genotype-phenotype correlation.Methods Nineteen patients with HCM were enrolled and tested by high throughput sequencing technology,clinical materials were analyzed with regard to genotype.Results Mutation was found in nine out of nineteen HCM patients.Most of them were sarcomere protein mutation with the exception of two cases with mutation of adenosine 5-monophosphate-activated protein kinase γ2 subunit(PRKAG2).Besides,two cases with double mutations were identified,referring to PRKAG2 and MYBPC3,and MYBPC3 and heavy chain myosin 7(MYH7).The detection rate of gene mutation was 47%.The patients of MYH7 mutation presented a younger onset age and more serious myocardial hypertrophy,while varying degrees of conduction block and myocardial hypertrophy could be found in 2 PRKAG2 mutation patients.Conclusions High throughput sequencing technology can be used as a high performance and efficient method for screening HCM mutation.It provides a promising opportunity for further research on the nature of HCM with genotype-phenotype analysis.
What problem does this paper attempt to address?